Citations for
1CYP19A1
Kinetic analysis of the three-step steroid aromatase reaction of human cytochrome P450 19A1.
Sohl CD, Guengerich FP.
J Biol Chem Biol Chem. 2010 Apr 12. [Epub ahead of print]PMID: 20385561 2010
2CYP19A1
Epigenetic mechanisms regulating CYP19 transcription in human breast adipose fibroblasts.
Knower KC, To SQ, Simpson ER, Clyne CD.
Mol Cell Endocrinol 321(2):123-30. Epub 2010 Mar 6.PMID: 20211687 2010
3CYP19A1
Aromatase expression in the normal and epileptic human hippocampus.
Yague JG, Azcoitia I, DeFelipe J, Garcia-Segura LM, Muņoz A.
Brain Res 1315:41-52. Epub 2009 Oct 6.PMID: 19815003 2010
4CYP19A1
The association between genetic polymorphisms in CYP19 and breast cancer risk in Korean women.
Kim JY, Lee CS, Kim HO, Jo YH, Lee J, Jung MH, Baik HH, Choe W, Kang I, Yoon KS.
Oncol Rep 22(3):487-92.PMID: 19639193 2009
5CYP19A1
The alternative noncoding exons 1 of aromatase (Cyp19) gene modulate gene expression in a posttranscriptional manner.
Wang H, Li R, Hu Y.
Endocrinology 150(7):3301-7. Epub 2009 Mar 12.PMID: 19282383 2009
6CYP19A1
Association of two common single-nucleotide polymorphisms in the CYP19A1 locus and ovarian cancer risk.
Goodman MT, Lurie G, Thompson PJ, McDuffie KE, Carney ME.
Endocr Relat Cancer 15(4):1055-60. Epub 2008 Jul 30.PMID: 18667686 2008
7AROD, CYP19A1
Loss of aromatase cytochrome P450 function as a risk factor for Parkinson's disease?
Morale MC, L'Episcopo F, Tirolo C, Giaquinta G, Caniglia S, Testa N, Arcieri P, Serra PA, Lupo G, Alberghina M, Harada N, Honda S, Panzica GC, Marchetti B.
Brain Res Rev 57(2):431-43. Epub 2007 Nov 7. Review.PMID: 18063054 2008
8CYP19A1, AROD
Variable Phenotypes Associated with Aromatase (CYP19) Insufficiency in Humans.
Lin L, Ercan O, Raza J, Burren CP, Creighton SM, Auchus RJ, Dattani MT, Achermann JC.
J Clin Endocrinol Metab 92(3):982-90. Epub 2006 Dec 12. 2007
9CYP19A1
Identification of an aromatase haplotype that is associated with gene expression and postmenopausal osteoporosis.
Riancho JA, Valero C, Naranjo A, Morales DJ, Sanudo C, Zarrabeitia MT.
J Clin Endocrinol Metab 92(2):660-5. Epub 2006 Nov 21. 2007
10CYP19A1
CYP19A1 polymorphisms are associated with bone mineral density in Chinese men.
Hong X, Hsu YH, Terwedow H, Arguelles LM, Tang G, Liu X, Zhang S, Xu X, Xu X.
Hum Genet 121(3-4):491-500. Epub 2007 Jan 11. 2007
11CYP19A1, AROE
Regional Rearrangements in Chromosome 15q21 Cause Formation of Cryptic Promoters for the CYP19 (Aromatase) Gene.
Demura M, Martin RM, Shozu M, Sebastian S, Takayama K, Hsu WT, Schultz RA, Neely K, Bryant M, Mendonca BB, Hanaki K, Kanzaki S, Rhoads DB, Misra M, Bulun SE.
Hum Mol Genet [Epub ahead of print] 2007
12CYP19A1, AROE
Aromatase excess in cancers of breast, endometrium and ovary.
Bulun SE, Chen D, Lu M, Zhao H, Cheng Y, Demura M, Yilmaz B, Martin R, Utsunomiya H, Thung S, Su E, Marsh E, Hakim A, Yin P, Ishikawa H, Amin S, Imir G, Gurates B, Attar E, Reierstad S, Innes J, Lin Z.
J Steroid Biochem Mol Biol 106(1-5):81-96. Epub 2007 May 24. 2007
13CYP17A1, CYP19A1
Polymorphisms of estrogen-biosynthesis genes CYP17 and CYP19 may influence age at menarche: a genetic association study in Caucasian females.
Guo Y, Xiong DH, Yang TL, Guo YF, Recker RR, Deng HW.
Hum Mol Genet 15(16):2401-8. Epub 2006 Jun 16. 2006
14FOXL2, CYP19A1
FOXL2 activates P450 aromatase gene transcription: towards a better characterization of the early steps of mammalian ovarian development.
Pannetier M, Fabre S, Batista F, Kocer A, Renault L, Jolivet G, Mandon-PŽpin B, Cotinot C, Veitia R, Pailhoux E.
J Mol Endocrinol 36(3):399-413. 2006
15CYP19A1, TRPM7
A potential rearrangement between CYP19 and TRPM7 genes on chromosome 15q21.2 as a cause of aromatase excess syndrome.
Tiulpakov A, Kalintchenko N, Semitcheva T, Polyakov A, Dedov I, Sverdlova P, Kolesnikova G, Peterkova V, Rubtsov P.
J Clin Endocrinol Metab 90(7):4184-90. Epub 2005 Apr 5. 2005
16AROD, CYP19A1, AROE, CGNL1
Estrogen excess associated with novel gain-of-function mutations affecting the aromatase gene.
Shozu M, Sebastian S, Takayama K, Hsu WT, Schultz RA, Neely K, Bryant M, Bulun SE.
N Engl J Med 348(19):1855-65. 2003
17CYP11A1, CYP11B1, CYP11B2, CYP17A1D, CYP19A1, GATA4, NR0B1, NR2F1, NR2F2, NR5A1, PCNA, COPS2
DAX1 and its network partners: exploring complexity in development.
Clipsham R, McCabe ER.
Mol Genet Metab 80(1-2):81-120. 2003
18CYP19A1, CRAC1
Chromosomal region 15q21.1 is a frequent target of allelic imbalance in advanced breast carcinomas.
Rhiem K, Klein A, Munch M, Kreutzfeld R, Ramser J, Wardelmann E, Schackert G, Von Deimling A, Wiestler OD, Schmutzler RK.
Int J Cancer 106(1):74-7. 2003
19CYP19A1
The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters.
Bulun SE, Sebastian S, Takayama K, Suzuki T, Sasano H, Shozu M.
J Steroid Biochem Mol Biol 86(3-5):219-24. Review. 2003
20CYP19A1
Cloning and characterization of a novel endothelial promoter of the human CYP19 (aromatase P450) gene that is up-regulated in breast cancer tissue.
Sebastian S, Takayama K, Shozu M, Bulun SE.
Mol Endocrinol 16(10):2243-54. 2002
21CYP19A1
CYP19 gene polymorphism in endometrial cancer patients.
Berstein LM, Imyanitov EN, Suspitsin EN, Grigoriev MY, Sokolov EP, Togo A, Hanson KP, Poroshina TE, Vasiljev DA, Kovalevskij AY, Gamajunova VB.
J Cancer Res Clin Oncol 127(2):135-8. 2001
22CYP19A1, SNAI1
Down-regulation of promoter 1.3 activity of the human aromatase gene in breast tissue by zinc-finger protein, snail (SnaH).
Okubo T, Truong TK, Yu B, Itoh T, Zhao J, Grube B, Zhou D, Chen S.
Cancer Res 61(4):1338-46. 2001
23CYP19A1
Expression of CYP19 (aromatase) mRNA in different areas of the human brain.
Stoffel-Wagner B, Watzka M, Schramm J, Bidlingmaier F, Klingmuller D.
J Steroid Biochem Mol Biol 70(4-6):237-41. 1999
24CYP19A1
Female pseudohermaphroditism associated with a novel homozygous G-to-A (V370-to-M) substitution in the P-450 aromatase gene.
Ludwig M, Beck A, Wickert L, Bolkenius U, Tittel B, Hinkel K, Bidlingmaier F.
J Pediatr Endocrinol Metab 11 : 657-664. 1998
25CYP19A1
Genetic mutations resulting in estrogen insufficiency in the male.
Simpson ER.
Mol Cell Endocrinol 145(1-2):55-9. 1998
26CYP19A1
Aromatase deficiency in a female who is compound heterozygote for two new point mutations in the P450arom gene: impact of estrogens on hypergonadotropic hypogonadism, multicystic ovaries, and bone densitometry in childhood.
Mullis PE, Yoshimura N, Kuhlmann B, Lippuner K, Jaeger P, Harada H.
J Clin Endocrinol Metab 82(6):1739-45. 1997
27CYP19A1
Alternatively spliced transcripts of the aromatase cytochrome P450 (CYP19) gene in adipose tissue of women.
Agarwal VR, Ashanullah CI, Simpson ER, Bulun SE.
J Clin Endocrinol Metab 82(1):70-4. 1997
28CYP19A1
A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom).
Conte FA, et al.
J Clin Endocrinol Metab 78 : 1287-1292. 1994
29CYP19A1
Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries.
Ito Y, et al.
Proc Natl Acad Sci U S A 90 : 11673-11677. 1993
30CYP19A1
Molecular cloning of a cDNA showing alternative splicing of the 5'-untranslated sequence of mRNA for human aromatase P-450.
Toda K, Shizuta Y.
Eur J Biochem 213(1):383-9. 1993
31CYP19A1
Genetic studies to characterize the origin of the mutation in placental aromatase deficiency.
Harada N, et al.
Am J Hum Genet 51 : 666-672. 1992
32CYP19A1
Biochemical and molecular genetic analyses on placental aromatase (P-450AROM) deficiency.
Harada N, et al.
J Biol Chem 267 : 4781-4785. 1992
33CYP19A1
Tetranucleotide repeat polymorphism at the human aromatase cytochrome P-450 gene.
Polymeropoulos MH, et al.
Nucleic Acids Res 19 : 195. 1991
34CYP19A1
Human aromatase : cDNA cloning, southern blot analysis, and assignment of the gene to chromosome 15.
Chen S, et al.
DNA 7 : 27-38. 1988
35CYP19A1
Assignment of the aromatase gene to human chromosome 15q21.
Sparkes RS, et al.
(HGM9) Cytogenet Cell Genet 46 : 696. 1987
36CYP19A1
Familial gynecomastia with increased extraglandular aromatization of plasma carbon (19)-steroids.
Berkovitz GD, et al.
J Clin Invest 75 : 1763-1769. 1985
37CYP19A1
Massive extraglandular aromatization of plasma androstenedione resulting in feminization of a prepuberal boy.
Hemsell DL, et al.
J Clin Invest 60 : 455-464. 1977